What is pulmonary rehabilitation?

[NOTE: This article has been posted prior to peer review for use in an active research program. This content will be updated with a peer reviewed version as soon as it is available.]

Pulmonary rehabilitation is a comprehensive, evidence-based program designed to improve the physical and psychological well-being of individuals living with chronic respiratory diseases. Delivered by a multidisciplinary team, pulmonary rehab is based on a detailed assessment of each patient and includes personalized therapies such as exercise training, education, and behavior modification. The goal is to enhance quality of life, increase functional capacity, and support long-term adherence to health-promoting behaviors.

Patient Selection and Indications

Pulmonary rehab is appropriate for patients with stable chronic lung disease who have persistent symptoms, such as dyspnea, exercise limitation, or fatigue, and functional impairment ¹ Patients across all GOLD (Global Initiative for COPD) stages, including those with mild to moderate COPD, derive clinically meaningful benefit.² Indications also include frequent exacerbations, recent hospitalization, or progressive loss of exercise tolerance.{Rochester, 2023 #233}

Program Structure and Logistics

Pulmonary rehab programs are delivered in outpatient hospital settings, clinics, or community facilities and are typically supervised by a multidisciplinary team that may include pulmonologists, nurses, respiratory therapists, physical therapists, occupational therapists, exercise physiologists, dietitians, and psychologists.³ Programs are usually conducted two to three times per week for six to twelve weeks, with a typical course including 24 sessions over 12 weeks. Sessions last 1–2 hours and involve supervised exercise training, education, and self-management support.⁴

Core Components

Exercise training is a major component of pulmonary rehab, and includes endurance training (i.e. treadmill, cycle ergometer), strength training, and flexibility exercises. High-intensity exercise promotes physiologic adaptations such as increased oxidative enzyme activity, enhanced aerobic metabolism, and decreased lactic acid production, resulting in improved muscle endurance and delayed fatigue onset.⁵ In 16 trials involving 669 participants, the weighted mean improvement in functional exercise capacity, assessed on the basis of the distance walked in 6 minutes, was 48m. This approximated the estimated minimum clinically important difference of 50m.⁵ Fatigue, as measured by exercise tolerance, decreased with participation in a pulmonary rehab program for COPD patients, with exercise tolerance increasing significantly 3 weeks after completion of the program.⁶

The explanation of breathing retraining techniques, such as pursed-lip breathing, diaphragmatic breathing, and yoga-based practices are taught to improve ventilatory efficiency.⁷ Education sessions address disease understanding, inhaler technique, exacerbation recognition, energy conservation strategies, stress management, and oxygen use when indicated. Many programs also include psychological counseling, smoking cessation support, and nutritional counseling to optimize overall health status.³

Safety and Risks

Pulmonary rehab is low risk and safe, with very low rates of adverse events. Rare complications include musculoskeletal injury or cardiac events, which are promptly addressed in the supervised setting.⁸ Patients are typically screened with exercise stress tests or six-minute walk tests before participation to ensure safety and guide exercise prescriptions.

Evidence of Clinical Benefits

Pulmonary rehab produces robust improvements across multiple clinically meaningful outcomes. In a multicenter cohort of 1,522 patients hospitalized for COPD exacerbations, those initiating pulmonary rehab within 90 days had a 37% lower risk of all-cause mortality at one year (HR 0.63, 95% CI 0.57–0.69).⁹ Meta-analysis of 13 randomized trials (n=801) found that pulmonary rehabilitation reduced number of days in hospital by 4.27 days (1 trial, 180 patients; 95% CL: [-6.85 to -1.69]) and hospital readmissions (6 trials, 319 patients; RR=0.47 [95% CI: 0.29 to 0.75])).¹⁰ Exercise capacity improves significantly, with mean increases in six-minute walk distance of ~54 meters¹¹ and peak VO₂ gains of  84.8 mL/min (p < 0.0001) from baseline after 8–12 weeks.¹² Quality of life improves by 4–6 points on the St. George Respiratory Questionnaire (SGRQ) and approximately 5 points on the Chronic Respiratory Disease Questionnaire (CRQ), exceeding the minimal clinically important difference for both.¹³ Symptoms of anxiety and depression decrease, with moderate effect sizes reported in meta-analyses.{Gordon, 2019 #234}

Although PR does not reverse airflow limitation, longitudinal studies suggest it may attenuate the rate of FEV₁ decline by 2.8% compared with usual care.⁴ Patients also report decreased dyspnea, improved emotional well-being, and greater confidence in managing their condition.⁴ Physiologic benefits translate into improved ability to perform activities of daily living, participate in social activities, and maintain independence.

Smoking Cessation and Disease Self-Management

Integration of smoking cessation into pulmonary rehab programs enhances quit rates, leveraging the structured environment and reinforcement from peers and staff.¹⁵ Education on self-management reduces exacerbation frequency, improves inhaler adherence, and lowers health care utilization.

Pulmonary rehabilitation is a cornerstone intervention for individuals with chronic respiratory diseases, offering significant improvements in exercise capacity, symptom control, psychological well-being, and overall quality of life.{Rochester, 2023 #233} Its multidisciplinary, patient-centered approach, encompassing exercise training, education, and behavioral support, not only enhances functional status but also reduces hospitalizations and mortality.{Shenoy MA, 2023 #113}{McCarthy, 2015 #114} With a strong safety profile and proven clinical benefits across disease stages, pulmonary rehab is a standard component of comprehensive care for patients with chronic lung disease.{Saito, 2017 #118} Ongoing participation, especially after exacerbations or functional decline, along with integration of smoking cessation and self-management education, further reinforces its long-term impact on COPD health outcomes.{Lindenauer, 2020 #119}{Plankeel, 2005 #122}{Ryrso, 2018 #120}

References

1. Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. Dec 12 2012;12(12):CD000998. doi:10.1002/14651858.CD000998.pub3
2. Safka KA, Wald J, Wang H, McIvor L, McIvor A. GOLD Stage and Treatment in COPD: A 500 Patient Point Prevalence Study. Chronic Obstr Pulm Dis. Dec 22 2016;4(1):45-55. doi:10.15326/jcopdf.4.1.2016.0126
3. Shenoy MA PV. StatPearls, ed. Pulmonary Rehabilitation. StatPearls Publishing; 2023.
4. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. Feb 23 2015;2015(2):CD003793. doi:10.1002/14651858.CD003793.pub3
5. Casaburi R, ZuWallack R. Pulmonary rehabilitation for management of chronic obstructive pulmonary disease. N Engl J Med. Mar 26 2009;360(13):1329-35. doi:10.1056/NEJMct0804632
6. Wong CJ, Goodridge D, Marciniuk DD, Rennie D. Fatigue in patients with COPD participating in a pulmonary rehabilitation program. Int J Chron Obstruct Pulmon Dis. Oct 5 2010;5:319-26. doi:10.2147/COPD.S12321
7. Gosselink R. Breathing techniques in patients with chronic obstructive pulmonary disease (COPD). Chron Respir Dis. 2004;1(3):163-72. doi:10.1191/1479972304cd020rs
8. Saito H, Hatakeyama K, Konno H, Matsunaga T, Shimada Y, Minamiya Y. Impact of pulmonary rehabilitation on postoperative complications in patients with lung cancer and chronic obstructive pulmonary disease. Thorac Cancer. Sep 2017;8(5):451-460. doi:10.1111/1759-7714.12466
9. Lindenauer PK, Stefan MS, Pekow PS, et al. Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries. JAMA. May 12 2020;323(18):1813-1823. doi:10.1001/jama.2020.4437
10. Ryrso CK, Godtfredsen NS, Kofod LM, et al. Lower mortality after early supervised pulmonary rehabilitation following COPD-exacerbations: a systematic review and meta-analysis. BMC Pulm Med. Sep 15 2018;18(1):154. doi:10.1186/s12890-018-0718-1
11. Riario-Sforza GG, Incorvaia C, Paterniti F, et al. Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: a number needed to treat study. Int J Chron Obstruct Pulmon Dis. 2009;4:315-9. doi:10.2147/copd.s5905
12. Plankeel JF, McMullen B, MacIntyre NR. Exercise outcomes after pulmonary rehabilitation depend on the initial mechanism of exercise limitation among non-oxygen-dependent COPD patients. Chest. Jan 2005;127(1):110-6. doi:10.1378/chest.127.1.110
13. Man WD, Polkey MI, Donaldson N, Gray BJ, Moxham J. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ. Nov 20 2004;329(7476):1209. doi:10.1136/bmj.38258.662720.3A
14. Burge AT, Gadowski AM, Jones A, et al. Breathing techniques to reduce symptoms in people with serious respiratory illness: a systematic review. Eur Respir Rev. Oct 2024;33(174)doi:10.1183/16000617.0012-2024
15. Coleman SRM, Menson KE, Kaminsky DA, Gaalema DE. Smoking Cessation Interventions for Patients With Chronic Obstructive Pulmonary Disease: A NARRATIVE REVIEW WITH IMPLICATIONS FOR PULMONARY REHABILITATION. J Cardiopulm Rehabil Prev. Jul 1 2023;43(4):259-269. doi:10.1097/HCR.0000000000000764